Author:
Søholm Uffe,Broadley Melanie,Zaremba Natalie,Divilly Patrick,Baumann Petra Martina,Mahmoudi Zeinab,Martine-Edith Gilberte,Mader Julia K.,Cigler Monika,Brøsen Julie Maria Bøggild,Vaag Allan,Heller Simon,Pedersen-Bjergaard Ulrik,McCrimmon Rory J.,Renard Eric,Evans Mark,de Galan Bastiaan,Abbink Evertine,Amiel Stephanie A.,Hendrieckx Christel,Speight Jane,Choudhary Pratik,Pouwer Frans,
Abstract
Abstract
Aims/hypothesis
The aim of this work was to examine the impact of hypoglycaemia on daily functioning among adults with type 1 diabetes or insulin-treated type 2 diabetes, using the novel Hypo-METRICS app.
Methods
For 70 consecutive days, 594 adults (type 1 diabetes, n=274; type 2 diabetes, n=320) completed brief morning and evening Hypo-METRICS ‘check-ins’ about their experienced hypoglycaemia and daily functioning. Participants wore a blinded glucose sensor (i.e. data unavailable to the participants) for the study duration. Days and nights with or without person-reported hypoglycaemia (PRH) and/or sensor-detected hypoglycaemia (SDH) were compared using multilevel regression models.
Results
Participants submitted a mean ± SD of 86.3±12.5% morning and 90.8±10.7% evening check-ins. For both types of diabetes, SDH alone had no significant associations with the changes in daily functioning scores. However, daytime and night-time PRH (with or without SDH) were significantly associated with worsening of energy levels, mood, cognitive functioning, negative affect and fear of hypoglycaemia later that day or while asleep. In addition, night-time PRH (with or without SDH) was significantly associated with worsening of sleep quality (type 1 and type 2 diabetes) and memory (type 2 diabetes). Further, daytime PRH (with or without SDH), was associated with worsening of fear of hyperglycaemia while asleep (type 1 diabetes), memory (type 1 and type 2 diabetes) and social functioning (type 2 diabetes).
Conclusions/interpretation
This prospective, real-world study reveals impact on several domains of daily functioning following PRH but not following SDH alone. These data suggest that the observed negative impact is mainly driven by subjective awareness of hypoglycaemia (i.e. PRH), through either symptoms or sensor alerts/readings and/or the need to take action to prevent or treat episodes.
Graphical Abstract
Funder
Innovative Medicines Initiative 2 Joint Undertaking
University of Southern Denmark
Publisher
Springer Science and Business Media LLC